RXMD
2024-06-30 | ||||
---|---|---|---|---|
Revenues, net | 13,477 | |||
Costs of revenue | 8,782 | |||
Gross profit | 4,695 | |||
Selling, general, and administrative | 895 | |||
Professional fees | 384 | |||
Salaries and wages | 2,166 | |||
Depreciation and amortization | 757 | |||
Impairment loss | 9,792 | |||
Total operating expenses | 13,994 | |||
Loss from operations | -9,299 | |||
Interest income | 40 | |||
Us-gaap_interestexpensenonoperating | 17 | |||
Us-gaap_nonoperatingincomeexpense | 23 | |||
Us-gaap_incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest | -9,276 | |||
Net income (loss) | -9,276 | |||
Basic eps | -1.49 | |||
Diluted eps | -1.49 | |||
Basic average shares | 6,241,000 | |||
Diluted average shares | 6,241,000 |